ASCO Publications

Novel Computational Pipeline Enables Reliable Diagnosis of Inverted Urothelial Papilloma and Distinguishes It From Urothelial Carcinoma ascopubs.org/doi/10.1200/... #JCOCCI #JCOJournals

ASCO Publications

Ensuring Representation: A Scoping Review of Interventions to Increase Minority Participation in Cancer-Related Research ascopubs.org/doi/10.1200/... #JCOOP #JCOJournals

Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer | JCO Oncology Practice PURPOSEMany patients with prostate cancer are eligible for germline genetic testing, but it is underutilized in clinical practice. We aimed to explore perceptions of and decision making about undergoi...

Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer ascopubs.org/doi/10.1200/...
#JCOOP #JCOJournals @ethicsdoctorp.bsky.social @jameabraham.bsky.social

ASCO Publications

Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation ascopubs.org/doi/10.1200/... #JCOPO #PrecisionOnc #JCOJournals #OpenAccess

ASCO Publications

"These results demonstrate the feasibility of implementing natural language processing tools in the routine of a cancer center to extract and code valuable information from pathology reports." ascopubs.org/doi/10.1200/... #JCOCCI #JCOJournals #OpenAccess

ASCO Publications

Health Information Disparities Among Asian American People With Cancer ascopubs.org/doi/10.1200/...
#JCOOP #JCOJournals

ASCO Publications

ICYMI: Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status ascopubs.org/doi/10.1200/...
#JCO #JCOJournals #BreastCancer #OpenAccess

ASCO Publications

Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma? ascopubs.org/doi/10.1200/...

#JCO #JCOJournals #Comments&Controversies

ASCO Publications

Childhood Cancer Survivorship Care in Limited Resource Settings: A Narrative Review and Strategies to Promote Global Health Equity ascopubs.org/doi/10.1200/...
#JCOGO #JCOJournals #OpenAccess

Real-World Patient-Reported Outcome Measure Implementation: Challenges and Successes of a Pan-Canadian Initiative to Improve the Future of Patient-Centered Cancer Care | JCO Oncology Practice PURPOSEImplementation of patient-reported outcome measures (PROMs) in routine care continues to be limited, despite their demonstrated efficacy and substantial investments. We report on the lessons le...

ICYMI: Real-World Patient-Reported Outcome Measure Implementation: Challenges and Successes of a Pan-Canadian Initiative to Improve the Future of Patient-Centered Cancer Care ascopubs.org/doi/10.1200/...
#JCOOP #JCOJournals

ASCO Publications

Safety and efficacy of neoadjuvant durvalumab plus gemcitabine/cisplatin or carboplatin in patients with operable high-risk upper tract urothelial carcinoma: the iNDUCT trial
ascopubs.org/doi/10.1200/...
#JCO #JCORapidCommunication #JCOJournals

COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts PURPOSEThe COSMIC-021 study assessed the safety and efficacy of cabozantinib plus atezolizumab in advanced solid tumors. Presented here are results from the expansion cohorts with advanced urothelial ...

COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts ascopubs.org/doi/10.1200/...
#JCO #JCOJournals #OpenAccess #ClinicalTrial

ASCO Publications

New from #JCOGO: Continued Promise and Possibility of Prospective Payment System Exemption: An Investment in the Future of Cancer Care Innovation ascopubs.org/doi/10.1200/...
#JCOJournals #GlobalOncology

Continued Promise and Possibility of Prospective Payment System Exemption: An Investment in the Future of Cancer Care Innovation | JCO Oncology Practice

Continued Promise and Possibility of Prospective Payment System Exemption: An Investment in the Future of Cancer Care Innovation ascopubs.org/doi/10.1200/... #JCOOP #JCOJournals #FreetoRead

Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?

Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer? ascopubs.org/doi/10.1200/... #JCOJournals #JCO #Oncsky

State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023 | JCO Oncology Advances PURPOSERecent data suggest that the rate of burnout among oncologists has risen over time. In addition to the negative effect of burnout on individuals, widespread burnout may prevent the oncology wor...

New from #JCOOA: "Oncologists ... are experiencing higher rates of burnout compared with a decade ago. System-based interventions ... are necessary to maintaining an adequate workforce to provide care for current and future patients..." ascopubs.org/doi/10.1200/...
#JCOOA #JCOJournals #OpenAccess

ASCO Publications

In #JCO: "The calibrated potency of the 1XX CAR affords excellent efficacy at low cell doses with favorable toxicity profiles and may benefit the treatment of other hematologic malignancies, solid tumors, and autoimmunity." ascopubs.org/doi/10.1200/...
#JCOJournals

Navigating Disagreements on Health Information: How Patients With Cancer Perceive Health Care Providers' Approaches to Discussing Patient-Identified Information | JCO Oncology Practice PURPOSEAlthough publicly available cancer-related information online and offline could help patients make informed decisions, it also poses challenges due to prevalent misinformation. Patients need pr...

ICYMI: Navigating Disagreements on Health Information: How Patients With Cancer Perceive Health Care Providers' Approaches to Discussing Patient-Identified Information ascopubs.org/doi/10.1200/... #JCOOP #JCOJournals

Rx for Resilience: Curing Burnout in Oncology Through Smarter Workflows and Supportive Practices | JCO Oncology Practice

Rx for Resilience: Curing Burnout in Oncology Through Smarter Workflows and Supportive Practices
ascopubs.org/doi/10.1200/...
#JCOOP #JCOJournals #Burnout

Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial | JCO Precision Oncology PURPOSEFibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein overexpression is an emerging biomarker in gastric cancer and gastroesophageal junction cancer (GC). We assessed FGFR2b protein...

Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial ascopubs.org/doi/10.1200/...
#JCOPO #JCOJournals #PrecisionOncology #OpenAccess

ASCO Publications

Out in #JCOGO: Survival Outcomes for Adolescent and Young Adults With Cancer in Low- and Middle-Income Countries: A Systematic Review ascopubs.org/doi/10.1200/...
#GlobalOncology #AYACancer #JCOJournals

Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Association and ASCO Quality Training P... PURPOSEThe Hematology Oncology Pharmacist Association Oral Chemotherapy Collaborative (HOPA OCC) developed practice-based tools to use in program development and improvement for the management of pati...

ICYMI: Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Association and #ASCOQuality ascopubs.org/doi/10.1200/...
#JCOOP #JCOJournals

ASCO Publications

New! #ClinicalTrialUpdate from #JCO: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis ascopubs.org/doi/10.1200/...
#JCOjournals #OpenAccess

ASCO Publications

Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency ascopubs.org/doi/10.1200/...
#JCOOP #JCOJournals

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO G...

Just published! New ASCO Guideline Update: Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update ascopubs.org/doi/10.1200/...
#JCO #JCOJournals #Guidelines

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ascopubs.org/doi/10.1200/...
#JCO #JCOJournals #BreastCancer

Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials: An Ethical Imperative

Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials: An Ethical Imperative ascopubs.org/doi/10.1200/...
#JCO #JCOJournals

De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence? Immune checkpoint blockers (ICBs) have revolutionized the treatment of non–small cell lung cancer (NSCLC). Currently, one-dose-fits-all maximalist regimens have been considered the standard of care, w...

De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence? ascopubs.org/doi/10.1200/... #JCO #JCOJournals #NSCLC #oncsky

#JCOJournals are so excited about the launch of a new podcast from JCO Oncology Practice. This first episode, featuring host @fumikochino.bsky.social, is Debt or Dying: The JCO OP Financial Toxicity Special Issue. Don't miss it!
ascopubs.org/do/debt-dyin...

NEW PODCAST SERIES from JCO Oncology Practice-- "JCO OP: Put into Practice" with our host @fumikochino.bsky.social. The first episode of this monthly series discusses the recent special issue on #financialtoxicity. Give it a listen: ascopubs.org/do/debt-dyin... #JCOOP #JCOJournals #podcast #oncsky